186 related articles for article (PubMed ID: 26112807)
1. The inflammatory microenvironment in brain metastases: potential treatment target?
Berghoff AS; Preusser M
Chin Clin Oncol; 2015 Jun; 4(2):21. PubMed ID: 26112807
[TBL] [Abstract][Full Text] [Related]
2. Tumor infiltrating lymphocytes and PD-L1 expression in brain metastases of small cell lung cancer (SCLC).
Berghoff AS; Ricken G; Wilhelm D; Rajky O; Widhalm G; Dieckmann K; Birner P; Bartsch R; Preusser M
J Neurooncol; 2016 Oct; 130(1):19-29. PubMed ID: 27436101
[TBL] [Abstract][Full Text] [Related]
3. Prevailing over T cell exhaustion: New developments in the immunotherapy of pancreatic cancer.
Bauer C; Kühnemuth B; Duewell P; Ormanns S; Gress T; Schnurr M
Cancer Lett; 2016 Oct; 381(1):259-68. PubMed ID: 26968250
[TBL] [Abstract][Full Text] [Related]
4. Tumour-infiltrating lymphocytes and expression of programmed death ligand 1 (PD-L1) in melanoma brain metastases.
Berghoff AS; Ricken G; Widhalm G; Rajky O; Dieckmann K; Birner P; Bartsch R; Höller C; Preusser M
Histopathology; 2015 Jan; 66(2):289-99. PubMed ID: 25314639
[TBL] [Abstract][Full Text] [Related]
5. Supportive roles of brain macrophages in CNS metastases and assessment of new approaches targeting their functions.
You H; Baluszek S; Kaminska B
Theranostics; 2020; 10(7):2949-2964. PubMed ID: 32194848
[TBL] [Abstract][Full Text] [Related]
6. Immune Microenvironment of Brain Metastases-Are Microglia and Other Brain Macrophages Little Helpers?
You H; Baluszek S; Kaminska B
Front Immunol; 2019; 10():1941. PubMed ID: 31481958
[TBL] [Abstract][Full Text] [Related]
7. Immunomodulation in cancer.
Hegmans JP; Aerts JG
Curr Opin Pharmacol; 2014 Aug; 17():17-21. PubMed ID: 25011112
[TBL] [Abstract][Full Text] [Related]
8. Expected Paradigm Shift in Brain Metastases Therapy-Immune Checkpoint Inhibitors.
Jindal V; Gupta S
Mol Neurobiol; 2018 Aug; 55(8):7072-7078. PubMed ID: 29383686
[TBL] [Abstract][Full Text] [Related]
9. Antibody Blockade of Semaphorin 4D Promotes Immune Infiltration into Tumor and Enhances Response to Other Immunomodulatory Therapies.
Evans EE; Jonason AS; Bussler H; Torno S; Veeraraghavan J; Reilly C; Doherty MA; Seils J; Winter LA; Mallow C; Kirk R; Howell A; Giralico S; Scrivens M; Klimatcheva K; Fisher TL; Bowers WJ; Paris M; Smith ES; Zauderer M
Cancer Immunol Res; 2015 Jun; 3(6):689-701. PubMed ID: 25614511
[TBL] [Abstract][Full Text] [Related]
10. Protective role of the inflammatory CCR2/CCL2 chemokine pathway through recruitment of type 1 cytotoxic γδ T lymphocytes to tumor beds.
Lança T; Costa MF; Gonçalves-Sousa N; Rei M; Grosso AR; Penido C; Silva-Santos B
J Immunol; 2013 Jun; 190(12):6673-80. PubMed ID: 23686489
[TBL] [Abstract][Full Text] [Related]
11. Systemic therapies for melanoma brain metastases: which drug for whom and when?
Ramanujam S; Schadendorf D; Long GV
Chin Clin Oncol; 2015 Jun; 4(2):25. PubMed ID: 26112811
[TBL] [Abstract][Full Text] [Related]
12. Immune cells in the melanoma microenvironment hold information for prediction of the risk of recurrence and response to treatment.
Camisaschi C; Vallacchi V; Castelli C; Rivoltini L; Rodolfo M
Expert Rev Mol Diagn; 2014 Jul; 14(6):643-6. PubMed ID: 24914691
[TBL] [Abstract][Full Text] [Related]
13. Single-Cell Profiling Comparisons of Tumor Microenvironment between Primary Advanced Lung Adenocarcinomas and Brain Metastases and Machine Learning Algorithms in Predicting Immunotherapeutic Responses.
Wu Y; Kang K; Han C; Wang L; Wang Z; Zhao A
Biomolecules; 2023 Jan; 13(1):. PubMed ID: 36671569
[TBL] [Abstract][Full Text] [Related]
14. Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents.
Galluzzi L; Buqué A; Kepp O; Zitvogel L; Kroemer G
Cancer Cell; 2015 Dec; 28(6):690-714. PubMed ID: 26678337
[TBL] [Abstract][Full Text] [Related]
15. The future of targeted therapies for brain metastases.
Berghoff AS; Preusser M
Future Oncol; 2015; 11(16):2315-27. PubMed ID: 26260810
[TBL] [Abstract][Full Text] [Related]
16. Brain metastases: pathobiology and emerging targeted therapies.
Preusser M; Capper D; Ilhan-Mutlu A; Berghoff AS; Birner P; Bartsch R; Marosi C; Zielinski C; Mehta MP; Winkler F; Wick W; von Deimling A
Acta Neuropathol; 2012 Feb; 123(2):205-22. PubMed ID: 22212630
[TBL] [Abstract][Full Text] [Related]
17. Immunomodulatory Effects of Tryptophan Metabolism in the Glioma Tumor Microenvironment.
Xu Y; Zhang H; Sun Q; Geng R; Yuan F; Liu B; Chen Q
Front Immunol; 2021; 12():730289. PubMed ID: 34659216
[TBL] [Abstract][Full Text] [Related]
18. Cancer Immunotherapy Getting Brainy: Visualizing the Distinctive CNS Metastatic Niche to Illuminate Therapeutic Resistance.
Owyong M; Hosseini-Nassab N; Efe G; Honkala A; van den Bijgaart RJE; Plaks V; Smith BR
Drug Resist Updat; 2017 Nov; 33-35():23-35. PubMed ID: 29145972
[TBL] [Abstract][Full Text] [Related]
19. Focus on TILs: Prognostic significance of tumor infiltrating lymphocytes in human bladder cancer.
Liakou CI; Narayanan S; Ng Tang D; Logothetis CJ; Sharma P
Cancer Immun; 2007 Jun; 7():10. PubMed ID: 17591743
[TBL] [Abstract][Full Text] [Related]
20. Prognostic role of tumour-infiltrating inflammatory cells in brain tumours: literature review.
Bieńkowski M; Preusser M
Curr Opin Neurol; 2015 Dec; 28(6):647-58. PubMed ID: 26402405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]